Intellia paused both trials after receiving a report of grade 4 liver enzymes and increased total bilirubin in a patient in ...
A study volunteer receiving Intellia’s transthyretin amyloidosis treatment was hospitalized due to severe signs of liver ...
Zacks Investment Research on MSN
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...
The bioscience industry has been rapidly expanding with research, people, and ideas. This year’s third annual Bioscience Summit brings together those ideologies and more. “We just want to understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback